Cargando...
Flow cytometric monitoring for residual disease in B lymphoblastic leukemia post T cell engaging targeted therapies
The use of targeted therapy is growing in the setting of hematopoietic neoplasms. Flow cytometry is a cornerstone of residual disease monitoring post therapy in this group of malignancies. Often, there is overlap between antigens targeted by immunotherapies and gating reagents utilized for populatio...
Gardado en:
| Publicado en: | Curr Protoc Cytom |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6168357/ https://ncbi.nlm.nih.gov/pubmed/30212602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpcy.44 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|